全球一次性灌溉用品市場 - 市場規模（按細分市場）、份額、監管、報銷、治療、預測（~2033 年）

老年人口的增加和瓣膜退化是一次性灌溉用品市場的主要驅動因素。 心血管疾病盛行率的增加和生活方式的改變預計將在預測年內推動市場成長。

本報告研究和分析了全球一次性灌溉用品市場，並提供了有關每個細分市場的市場規模、市場趨勢、競爭格局以及 COVID-19 影響的資訊。

市場模型的主要內容如下。

市面上已有的一次性灌注用品以及不斷變化的競爭格局

• 對主要產業趨勢的考慮
• 一次性灌溉產品市場年收入與市場前景（按細分市場）（2015-2033 年）
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域和國家層面的特定市場考量

• 按地區細分全球趨勢的特定市場定性資訊和國家/地區考慮因素
• 一次性灌注用品市場SWOT分析
• 一次性灌注產品市場競爭動態的思考與趨勢

透過對醫療保健系統的真實、全面的了解來促進市場了解。 市場進入部分還提供有關報銷政策和監管環境的信息，使您能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技監理狀況

目標公司

• Terumo Corp
• Abbott Laboratories
• Medtronic Plc
• Getinge AB
• LivaNova Plc
• Nipro Corp
• Eurosets Srl
• Senko Medical Instrument Manufacturing Co Ltd
• Edwards Lifesciences Corp
• MicroPort Scientific Corp
• Abiomed Inc
• Braile Biomedica Ltda
• Fresenius SE & Co. KGaA
• 其他

Abstract

Perfusion Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Perfusion Disposables market for the year 2020 and beyond. Increase in aging population and valvular degeneration are major driving factors of the Perfusion Disposables market.

Growing prevalence of cardiovascular diseases and lifestyle changes is expected to drive market growth in forecast years. Valvular stenosis occurs when the heart valve narrows, restricting the blood flow across it. The narrowing of the valve causes the heart to work harder to supply adequate amounts of blood to the body and can cause heart failure. However, Valvular Regurgitation occurs due to leakage of blood through the valve, even when the leaflets are closed, or reverse flow of blood as the valve is closing. As a consequence, the heart supplies reduced volumes of blood.

Congenital heart defects, the most common type of birth defects, disrupt the normal flow of blood through the heart. patients suffering from coronary heart diseases (CHD), which results in insufficient blood supply to the heart, can be treated surgically through a CABG procedure. There are two basic ways of performing CABG procedures: On-pump and Off-pump CABG.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Perfusion Disposables and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Perfusion Disposables market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Perfusion Disposables market.
• Competitive dynamics insights and trends provided for Perfusion Disposables market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Terumo Corp, Abbott Laboratories, Medtronic Plc, Getinge AB, LivaNova Plc, Nipro Corp, Eurosets Srl, Senko Medical Instrument Manufacturing Co Ltd, Edwards Lifesciences Corp, MicroPort Scientific Corp, Abiomed Inc, Braile Biomedica Ltda, Fresenius SE & Co. KGaA, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Perfusion Disposables marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Perfusion Disposables market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Perfusion Disposables market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Perfusion Disposables market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Perfusion Disposables market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable